Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2125 of 6351
-
Radiation plus immunotherapy: a new hope for melanoma?
Disease control OngoingThe purpose of this study is compare the response rates in patients with metastatic melanoma treated with high-dose IL-2 to patients treated with high-dose IL-2 along with radiation therapy.
Phase 2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can ultrasound predict cancer drug response earlier?
Knowledge-focused CompletedRECIST criteria for evaluating tumor response are often inadequate for the evaluation of anti-angiogenic drugs. An evaluation model of tumor perfusion with contrast-enhanced ultrasonography was developed at Gustave Roussy. It assesses the tumor vascular response through the analy…
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can a daily shot of IL-2 tame chronic GVHD?
Disease control OngoingChronic GVHD is a medical condition that may occur after a bone marrow, stem cell or cord blood transplant. The donor's immune system may recognize the your body (the host) as foreign and attempt to 'reject' it. This process is known as graft-versus-host-disease. It is thought th…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can a Diaphragm-Sensing ventilator mode reduce breathing asynchrony?
Disease control CompletedMain hypothesis is that Neurally Adjusted Ventilatory Assist (NAVA) allows asynchrony reduction in non invasive ventilation (NIV) in comparison with reference Pressure Support (PSV) mode. The purpose of the protocol is to compare asynchrony rate between periods of pressure suppo…
Phase 1 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Pregnancy diabetes drugs studied for safety and effectiveness
Disease control CompletedThis is a pharmacokinetic and pharmacodynamic study evaluating glyburide, metformin, and combination treatment for gestational diabetes mellitus.
Phase 1/2 • Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Blood and swab tests could predict preterm birth risk
Knowledge-focused Stopped earlyDespite the progress made in the organization of care and neonatal care, prematurity remains the main cause of morbidity and perinatal mortality. This study aims to estimate the prognostic value of new biomarkers (proteomic markers) on the occurrence of preterm birth.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New ultrasound technique could sharpen liver surgery decisions
Diagnosis CompletedHypothesis: Use of contrast ultrasound showed interesting results, which can increase ultrasonography sensitivity performed during surgery in the evaluation of operable liver metastases. This study is a two-stage phase II multicenter study (Simon's two-stage).
Sponsor: Institut Bergonié • Aim: Diagnosis
Last updated Jun 26, 2026 13:12 UTC
-
Lung cancer combo shows promise in Second-Line trial
Disease control CompletedThis 2 arms study will compare the efficacy and safety of treatment with sequential erlotinib plus docetaxel therapy versus docetaxel alone as second line treatment in patients with recurrent non-small cell lung cancer. Patients will be randomized to receive in group 1(experiment…
Phase 2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Virtual reality offers new hope for chronic back pain sufferers
Symptom relief CompletedChronic low back pain and sciatica in adults represent a major medical and economic problem. During the chronic back pain (persisting continuously over 3 months), therapeutic responses to conventional pharmacologic type are often ineffective and the impact of pain is often heavy …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Spinal fluid injection shows promise for breast cancer brain spread
Disease control CompletedThe purpose of this study is: Phase I: To determine the Trastuzumab maximum tolerated dose (MTD) when weekly administrated by intrathecal or intraventricular route to reach a intra CSF target concentration (30 µg/mL) near the conventional therapeutic concentration and depending …
Phase 1/2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New test could slash misdiagnosis in kidney transplants
Diagnosis Recruiting nowThe current standard for biopsy-based diagnoses of dysfunction of kidney transplants is the Banff Classification which represents arbitrary international consensus. Recent data-driven approaches using molecular and conventional technologies indicate that mere consensus produces f…
Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy shows promise for lymphoma patients
Disease control CompletedThis randomized phase II trial studies how well ofatumumab and bendamustine hydrochloride with or without bortezomib works in treating patients with untreated follicular non-Hodgkin lymphoma. Monoclonal antibodies, such as ofatumumab, may block cancer growth in different ways by …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug cocktail shows promise for kids with resistant cancers
Disease control CompletedTherapeutic solutions to treat solid tumors that are resistant to conventional treatments are now limited. Laboratory data in animals (on pediatric tumors such as brain tumors, sarcomas and neuroblastomas) have shown that the combination of irinotecan (HIF1alpha inhibitor) and ra…
Phase 1 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Laser surgery or watchful waiting? trial seeks best care for twin syndrome
Disease control CompletedThe objective of this trial is to compare both strategies (Expectative Vs Fetoscopic laser surgery) for patients with stage 1 TTTS and favorable obstetrical parameters in an international randomized controlled trial. This trial will answer an important question and will help in t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Brain imaging duo may sharpen epilepsy surgery targeting
Knowledge-focused CompletedThe main goal of this study is to evaluate the additional value of EEG-fMRI method in the presurgical evaluation of focal intractable epilepsy. To consider a patient for surgery, the main difficulty is to define accurately the epileptogenic zone. This definition is complex and i…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New combo therapy for lung cancer shows promise in early trial
Disease control CompletedA multicenter, randomized, double-blind, placebo-controlled, phase 2 study of Erlotinib (Tarceva®) in combination with OSI-906 in Patients with Advanced non-small cell lung cancer (NSCLC) with Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene who are Chemon…
Phase 2 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Eye ultrasound could replace needles for measuring brain pressure in kids
Diagnosis CompletedIntracranial hypertension (ICH) is a mortality risk factor in severe traumatic brain injury (TBI), in purulent meningitis, in hepatic encephalopathy and in Reye's syndrome. It is also a risk factor for severe neurologic sequelae in survivors. Intracranial pressure (ICP) monitorin…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 26, 2026 13:26 UTC
-
Can a gentle electrical patch ease jaw pain faster?
Symptom relief CompletedTo evaluate whether adding conventional transcutaneous electrical nerve stimulation (TENS) to a standard conservative regimen (patient education, pharmacotherapy, and a home exercise programme) provides additional short- and medium-term benefit for pain, mandibular function, and …
Sponsor: Balikesir University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
New hope for HIV patients with Hard-to-Treat hepatitis c
Disease control CompletedThis phase II, multicentric, national pilot trial is designed to estimate the sustained virological response rate (SVR) following a 12 weeks treatment by telaprevir combined with a 48 or 72 weeks treatment by peginterferon and ribavirin, based upon the rapid virological response …
Phase 2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New cocktail of cancer drugs tested for Tough-to-Treat myeloma
Disease control OngoingThis study will evaluate the feasibility of combining four of the most active agents available for the treatment of multiple myeloma. Further the investigators will attempt to assess the activity of this combination.
Phase 1/2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC